Motion Sickness (Hyland’s)


Welcome to the PulseAid listing for the Motion Sickness drug offered from Hyland’s. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Hyland’s
NON-PROPRIETARY NAME: STRYCHNOS NUX-VOMICA SEED, TOBACCO LEAF, KEROSENE, and ANAMIRTA COCCULUS SEED
SUBSTANCE NAME: STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; KEROSENE; ANAMIRTA COCCULUS SEED
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, SOLUBLE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1994-12-01
END MARKETING DATE: 0000-00-00


Motion Sickness HUMAN OTC DRUG Details:

Item DescriptionMotion Sickness from Hyland’s
LABELER NAME: Hyland’s
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 12; 30([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 1994-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54973-9147_28db30c9-23b5-4301-ac23-459d5e442648
PRODUCT NDC: 54973-9147
APPLICATION NUMBER:

Other STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; KEROSENE; ANAMIRTA COCCULUS SEED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hyland’sMotion Sickness